26.05.2025 • Bookbooks

Natural and Synthetic Waxes

Natural and Synthetic Waxes, 1. Edition November 2022, E. J. Krendlinger, Deurex; 704 Pages, Hardcover, Handbook/Reference Book, €179,00; Wiley-VCH, Weinheim; ISBN: 978-3-527-34222-8

Author: E. J. Krendlinger, Deurex

Photo

With over 20 years of experience as technology and R&D manager in the industry, Ernst Krendlinger collates here all the relevant information on basic wax properties and processing technologies otherwise scattered across the literature and company brochures.

After a general introduction, he provides an overview of the chemistry of waxes including their composition, molecular structure and analysis. In addition, he discusses such physical properties as carbon chain length distribution, dropping point and acid number. Subsequent chapters deal with synthetic waxes from Fischer-Tropsch processes, paraffin and amide waxes as well as diverse wax blends and emulsions, summarizing how these waxes are produced and applied. The final chapter looks at natural waxes and their technical importance in industry, covering their production, properties and market situation.

This only up-to-date reference on the topic is essential reading in terms of the physical data as well as parameters and correlations, combining all the information necessary for the analysis and application of synthetic and natural wax compounds.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.